SMi are very pleased to present its inaugural event on Allergies.
Allergies represent one of the fastest growing chronic diseases. There is still no cure. There is increasing focus on the ways to treat allergies and less on the symptoms of allergic diseases. Companies are taking different approaches to control allergies in a more effective way.
The market for allergies is set to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, our 2014 event marks the path forward in terms of allergies within personalised medicines and beyond.
The conference will examine novel approaches in the treatment of allergy, advances in the understanding of allergic pathophysiology: therapeutic implications, food allergies - what is new? The future of allergen-specific immunotherapy and challenges in allergy prevention, diagnosis and drug development will be explored.
Electronic Access - Single User Fulfilled By Publisher